Put Options

16 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$10.32 - $12.13 $27,864 - $32,751
2,700 Added 5.54%
51,400 $596,000
Q2 2024

Aug 14, 2024

BUY
$10.05 - $12.02 $6,030 - $7,212
600 Added 1.25%
48,700 $517,000
Q1 2024

May 01, 2024

SELL
$11.27 - $13.53 $400,085 - $480,315
-35,500 Reduced 42.46%
48,100 $574,000
Q4 2023

Feb 12, 2024

BUY
$8.77 - $10.85 $245,560 - $303,800
28,000 Added 50.36%
83,600 $905,000
Q3 2023

Nov 13, 2023

BUY
$9.59 - $11.35 $34,524 - $40,860
3,600 Added 6.92%
55,600 $548,000
Q2 2023

Aug 10, 2023

BUY
$9.02 - $10.29 $13,530 - $15,434
1,500 Added 2.97%
52,000 $518,000
Q1 2023

May 09, 2023

SELL
$9.2 - $12.26 $333,960 - $445,038
-36,300 Reduced 41.82%
50,500 $485,000
Q4 2022

Feb 10, 2023

SELL
$8.72 - $11.56 $287,760 - $381,480
-33,000 Reduced 27.55%
86,800 $966,000
Q3 2022

Nov 10, 2022

BUY
$8.48 - $11.13 $64,448 - $84,588
7,600 Added 6.77%
119,800 $1.02 Million
Q2 2022

Aug 15, 2022

SELL
$9.95 - $12.27 $714,410 - $880,986
-71,800 Reduced 39.02%
112,200 $1.18 Million
Q1 2022

May 13, 2022

SELL
$9.81 - $15.4 $1.98 Million - $3.1 Million
-201,600 Reduced 52.28%
184,000 $2 Million
Q4 2021

Feb 11, 2022

SELL
$12.09 - $14.68 $338,520 - $411,040
-28,000 Reduced 6.77%
385,600 $5.22 Million
Q3 2021

Nov 15, 2021

BUY
$13.25 - $15.13 $2.01 Million - $2.29 Million
151,500 Added 57.8%
413,600 $5.6 Million
Q2 2021

Aug 16, 2021

SELL
$12.97 - $16.15 $20,752 - $25,839
-1,600 Reduced 0.61%
262,100 $3.75 Million
Q1 2021

May 17, 2021

BUY
$13.59 - $18.54 $1.54 Million - $2.1 Million
113,300 Added 75.33%
263,700 $3.68 Million
Q4 2020

Feb 16, 2021

BUY
$14.3 - $18.74 $2.15 Million - $2.82 Million
150,400 New
150,400 $2.82 Million

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.8B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Capstone Investment Advisors, LLC Portfolio

Follow Capstone Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capstone Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capstone Investment Advisors, LLC with notifications on news.